Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1105 | 1029 | 1312 | 911 | 1554 | - |
Fund Return | 10.52% | 2.89% | 31.24% | -3.08% | 9.21% | - |
Place in category | 283 | 325 | 296 | 293 | 285 | - |
% in Category | 53 | 55 | 56 | 62 | 62 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bridge Builder Large Cap Growth | 27.24B | 17.31 | 4.18 | - | ||
Bridge Builder Large Cap Value | 23.57B | 15.03 | 8.45 | - | ||
Bridge Builder International Equity | 18.86B | 9.13 | 1.28 | - | ||
Bridge Builder Municipal Bond | 15.52B | 1.69 | 0.23 | - | ||
Bridge Builder Small/Mid Cap Value | 9.08B | 11.46 | 5.99 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.68B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 13.49B | 7.79 | 0.27 | - | ||
Vanguard Mid-Cap Growth Index Admir | 12.13B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price Mid-Cap Growth | 12.66B | 7.68 | 0.14 | 10.48 | ||
T. Rowe Price New Horizons I | 10.95B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Tradeweb Markets | US8926721064 | 1.33 | 128.70 | +1.04% | |
argenx ADR | US04016X1019 | 1.31 | 595.04 | -0.72% | |
Axon Enterprise | US05464C1018 | 1.16 | 604.56 | +0.54% | |
West Pharmaceutical Services | US9553061055 | 1.15 | 338.12 | -1.71% | |
Tyler Technologies | US9022521051 | 1.08 | 614.28 | -0.42% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review